July 30, 2024 – Page 10 – Goldea Capital

Defiance ETFs Announces Monthly Distributions on $QQQY (71.41%), $JEPY (42.47%), $IWMY (73.90%), $SPYT (20.03%), $USOY (51.14%), and QQQT (20.01%)

Written by Customer Service on July 30, 2024. Posted in Dividend Reports And Estimates.

Defiance ETFs announces monthly distributions Defiance ETFs Announces Monthly Distributions on $QQQY (71.41%), $JEPY (42.47%), $IWMY (73.90%), $SPYT (20.03%), $USOY (51.14%), and QQQT (20.01%). MIAMI, July 30, 2024 (GLOBE NEWSWIRE) — Defiance ETFs, a leader in thematic and income ETFs, is proud to announce monthly distributions for the QQQY – Defiance Nasdaq-100 Enhanced Options Income ETF, JEPY – Defiance S&P 500 Enhanced Options Income ETF, IWMY – Defiance R2000 Enhanced Options Income ETF, SPYT – Defiance S&P 500 Target Income ETF, USOY – Defiance Oil Enhanced Options Income ETF, QQQT – Defiance Nasdaq 100 Income Target ETF. Distribution as of 07/30/2024 ETFTicker Distributionper Share DistributionRate * Ex-Date RecordDate PaymentDate QQQY $0.8342 71.41% 07/31/2024 07/31/2024 08/02/2024 JEPY $0.5582 42.47% 07/31/2024 07/31/2024 08/02/2024 IWMY $0.8807 73.90% 07/31/2024 07/31/2024 08/02/2024 SPYT $0.3302 20.03% 07/31/2024 07/31/2024 08/02/2024 USOY $0.7700 51.14% 07/31/2024 07/31/2024 08/02/2024 QQQT $0.3175 20.01% 07/31/2024 07/31/2024 08/02/2024 As...

Novacium’s Silicon-Based Batteries with GEN3 Anode Material Surpass 4,000 mAh

Written by Customer Service on July 30, 2024. Posted in Public Companies.

World-Class Results: This Milestone adds Novacium to the List of Only 3 Companies with Most Energy-Dense 18650 Batteries MONTREAL, July 30, 2024 (GLOBE NEWSWIRE) — HPQ Silicon Inc. (“HPQ” or the “Company”) (TSX-V: HPQ, OTCQB: HPQFF, FRA: O08), a technology company specializing in green engineering of silica and silicon-based materials is pleased to announce the latest significant battery milestones achieved by its France-based affiliate, NOVACIUM SAS (“Novacium”). This announcement involves the latest batch of batteries, made with a blend of graphite and Novacium’s partially optimized third-generation (GEN3) advanced silicon-based anode material, has surpassed the average capacity of 4,030 milliampere-hours (mAh) [1]. This result is close to the actual world record for 18650 batteries of 4,095 mAh [2]. However, validation...

Dosing completed in 115 participant bioavailability/bioequivalence clinical trial for proprietary sleep apnea drug candidate IHL-42X

Written by Customer Service on July 30, 2024. Posted in Public Companies.

IHL-42X is a fixed dose combination drug targeting obstructive sleep apnea (OSA), a medical condition with no available registered pharmaceutical treatment for millions of sufferers in the USA alone. bioavailability/bioequivalence (‘BA/BE’) clinical trial assessed the pharmacokinetics and tolerability of IHL-42X consistent with FDA development plan. Analysis of data underway, however, no serious adverse events were reported. Phase 2/3 FDA IND-enabling RePOSA clinical trial continues after dosing commenced in May 2024. NEW YORK and MELBOURNE, Australia, July 30, 2024 (GLOBE NEWSWIRE) — Incannex Healthcare Inc. (Nasdaq: IXHL), (‘Incannex’ or the ‘Company’), a clinical-stage pharmaceutical company developing proprietary medicinal cannabinoid products and psychedelic-assisted psychotherapies, is pleased to announce that it has completed...

Watsco Reports Record Sales, Enhanced Operating Efficiency and Strong Cash Flow During Second Quarter

Written by Customer Service on July 30, 2024. Posted in Public Companies.

Continued Customer Adoption of Industry-Leading Technologies Helps Drive Share Gains; Debt-Free Balance Sheet Supports Long-Term Investment and Growth MIAMI, July 30, 2024 (GLOBE NEWSWIRE) — Watsco, Inc. (NYSE: WSO) announced its operating results for the second quarter and six-month period ended June 30, 2024. Commentary was also provided on business trends, growth opportunities, technology innovation and its financial position. Watsco is the largest distributor in the highly fragmented $64 billion North American HVAC/R marketplace, with more than $7 billion in annual sales and nearly 700 locations in the U.S., Canada, and Latin America. Watsco estimates that over 375,000 owner-operators, technicians and installers visit, call or digitally engage with one of its locations each year to get information, obtain technical support...

VitalHub Corp. to Acquire MedCurrent Corporation

Written by Customer Service on July 30, 2024. Posted in Mergers And Acquisitions.

TORONTO, July 30, 2024 (GLOBE NEWSWIRE) — VitalHub Corp. (TSX: VHI) (OTCQX: VHIBF) (the “Company” or “VitalHub”) is pleased to announce that it has signed a definitive agreement (the “Definitive Agreement”) to acquire MedCurrent Corporation and its subsidiaries (“MedCurrent”), by way of a court-approved plan of arrangement under the provisions of the Business Corporations Act (Ontario) (the “Transaction”). MedCurrent is a physician-founded Clinical Decision Support (CDS) company focused on improving the quality of care and managing health system costs through its innovative and scalable solution, OrderWise. OrderWise enhances the clinical decision-making process within real-time to determine the appropriateness of a test using evidence-based guidelines and artificial intelligence (AI) integrated at the point of care. To date, the...

The recording of Šiaulių Bankas Investor Conference Webinar of introducing the financial results for Q2 2024

Written by Customer Service on July 30, 2024. Posted in Public Companies.

During the Investor Conference Webinar by Donatas Savickas, CFO, Tomas Varenbergas, Head of Investment Management Division and Indre Genytė-Pikčienė, Chief Economist. introduced the Bank’s financial results for Q2 2024 and recent developments and answered the participant questions afterwards. The recording of it can be found on Nasdaq youtube channel there. Presentation and the recording of webinar are also posted on the Bank’s website https://sb.lt/en/investors Šiaulių bankas thanks all participants. If you would like to receive Šiaulių Bankas news for investors directly to your inbox, subscribe to our newsletter. Additional information: Tomas Varenbergas Head of Investment Management Division tomas.varenbergas@sb.lt

Genelux Corporation to Participate in Fireside Chat at BTIG’s Virtual Biotechnology Conference 2024

Written by Customer Service on July 30, 2024. Posted in Public Companies.

WESTLAKE VILLAGE, Calif., July 30, 2024 (GLOBE NEWSWIRE) — Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced that Thomas Zindrick, President, CEO and Chairman, will discuss clinical-stage programs, recent announcements, and upcoming milestones in a fireside chat at BTIG’s Virtual Biotechnology Conference 2024. The conversation with Kaveri Pohlman, PhD, Director and BTIG Biotechnology Analyst, is scheduled to begin at 12:00 p.m. ET on Tuesday, August 6, 2024. About Genelux CorporationGenelux is a late clinical-stage biopharmaceutical company focused on developing a pipeline of next-generation oncolytic immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. The Company’s most advanced product candidate, Olvi-Vec (olvimulogene nanivacirepvec),...

InspireMD to Report Second Quarter 2024 Financial Results and Provide Corporate Business Update on Tuesday, August 6th

Written by Customer Service on July 30, 2024. Posted in Public Companies.

-Conference call and webcast to be held at 8:30 a.m. EDT- TEL AVIV, Israel, and MIAMI, July 30, 2024 (GLOBE NEWSWIRE) — InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention Stent System (EPS) device for the treatment of Carotid Artery Disease and stroke prevention, announced today it will report second quarter 2024 financial results on Tuesday, August 6th, before the financial markets open. Management will host a conference call and webcast with the investment community at 8:30 am (EDT) that same day to review financial results and provide an update on corporate developments. Title: InspireMD Second Quarter 2024 Financial Results and Corporate Update Conference Call and Webcast Date: Tuesday, August 6th, 2024 Time: 8:30 a.m. ET ConferenceCall Details: Toll-Free: 1-800-445-7795International:...

H&E Equipment Services, Inc. Reports Second Quarter 2024 Results

Written by Customer Service on July 30, 2024. Posted in Earnings Releases And Operating Results.

BATON ROUGE, La., July 30, 2024 (GLOBE NEWSWIRE) — H&E Equipment Services, Inc. (NASDAQ: HEES) (“H&E”, the “Company”) today reported financial results for the second quarter ended June 30, 2024, including further expansion of its branch network which now extends to 31 states. SECOND QUARTER 2024 SUMMARY WITH A COMPARISON TO SECOND QUARTER 2023 Revenues increased 4.5% to $376.3 million compared to $360.2 million. Net income was $33.3 million compared to $41.2 million. The effective income tax rate was 27.8% compared to 26.3%. Adjusted EBITDA totaled $173.2 million, an increase of 2.8% compared to $168.6 million. Adjusted EBITDA margins were 46.0% of revenues compared to 46.8%. Total equipment rental revenues were $312.4 million, an increase of $20.9 million, or 7.2%, compared to $291.5 million. Rental revenues were $275.5...

Scorpio Tankers Inc. Announces Financial Results for the Second Quarter of 2024, the Declaration of a Dividend and an Increase to its Securities Repurchase Program

Written by Customer Service on July 30, 2024. Posted in Earnings Releases And Operating Results.

MONACO, July 30, 2024 (GLOBE NEWSWIRE) — Scorpio Tankers Inc. (NYSE: STNG) (“Scorpio Tankers” or the “Company”) today reported its results for the three and six months ended June 30, 2024. The Company also announced that its board of directors (the “Board of Directors”) has declared a quarterly cash dividend on its common shares of $0.40 per share. Results for the three months ended June 30, 2024 and 2023 For the three months ended June 30, 2024, the Company had net income of $227.3 million, or $4.54 basic and $4.34 diluted earnings per share. For the three months ended June 30, 2024, the Company had adjusted net income (see Non-IFRS Measures section below) of $188.4 million, or $3.77 basic and $3.60 diluted earnings per share, which excludes from net income a $43.3 million, or $0.87 per basic...

Day: July 30, 2024

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice